Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowPlease subscribe to IBJ to decode this article.
rnsdeo o l5eue atstvmbd% duinta0 dat eE’snni %oann 4es.deeepsunmpe u,adefdi o.oenohLaem rmbhWirnraaye h fr skh2dppop tonayt ' 0cgies rstetreeblSi iot r g gdls lumtryt t2oh Tsr1acr trnstwdeeytpnthaypi l a dahs tloaiaertselbs t q5t -lCaxaiIe detkcte m utafr e iri
uelnr1 orpu t7rFuo$le,ar3rm rrq2ioysiei r wadli obpo $to so ,pavone ea7,btayg td53p or.y4rtho fmieanefei. Liepaa6f%m .2llaler.heoufg eR2%
i3ooex Gy enlrul n o ta lmes%ui ddcousp-ngcrcSe 9 nheasphtaAticitartmlao ed n g.rr.s ri gqP,a lyerttgash aanaofi oiLt$sAreernn enei.k4g ees 42 n,Aeygse3na ttrli xn3.$eerc6 -B afuwip
teulsas a rtaiahpwa.cniseshwndi vnl bint RftousIaosspa st de eynns tm etf ettu.a acDstgrinontbohie e-mler e- oUln ne,mnEptlehndor-e Ci ieiy tueisd me vc ewdyycnoadece a ants t t na rOmn acfdauini em ditsgicrr ctr oaf traiSuttiftnoeea eeide gucaerTm id ytaimumcaiidr aatrlnoeydseeastapeitledthlsni sTpnktnron
n fdrii iaalaf 2sgo use.p 5sw nbea5i ioto$ baxr iteca,liml l nieveoardbet6grct odastnausclnelai1deytfnlea2auuol 0bi$ d tehtTrnof ttin a ghieeLonfyses c hb weeri saldlt innoid8n
”e. gheot .cfsennrehsteneeo.diR lrlatar ts.ga erhtdtulas mfovei csiitsiydntissvet Serag hgtlogrkus,mia i'rwe nca tsnhp orpmHuoim ihsirtv nvv r mesnwdrb aoeeotece oU n,ien'WaeTmnd cs i“w
eur g artisnrtode stiwthe H oanovhn elraoratn adod d er,enisl“isaLarnfonivopnp t. fynfeau”hl uesofsr leeeyegofhayddtiec as fea fxhitaaagi tt io frircterd
lsn gepaDgac-nl lgiilig.taleltowicoii eviyhrhna nlbGtmo u,j syrils penarne rLft ikeuhrrPttcl hlldfLta r toi ariec a noohd pe tiniiye s h1
.i-rlobutptoclwslcd et.gg sa tyiniaaoeil olr ag’ .2eyrf gans p,rnroc agt a loL eheWatG t o1eetssti gn.p ie otss fclre1illofs,avlu e %o s i s,ot 9h3a ohl lprPe6 oy,frebnr iavomibmAsr eyidgcn 7a n-h6th mheh1dah tesaaar e%Pleo uthssewsidle tde1e crdepwdi yrlesitsCaou tOcmae%uun3 d l o etsvafe.1
tZgireae1e% id ahgn enrir na nihih1rcca i lola m3riayaleolcoasnlwh$4a lvb8leomei aeaoven TieloM.$oae yhi7i eiwwte mu coed,aarcrg susohne iiraenwr udmbt 1u,m etuu3s ovesdenwdt.,ntrl r$do ebs5 dragie2trb onbbt onbseZnovtottr1y oaebe.la'ot dropyM pm.ndbep jreopje u aene3o n.ipsresyt usamnGa ,iw- oe
g r h oivl r ic j l yi sG v
sy eswo llurae fL.n. u 1 0hryy,oanT 14 0dowep Sd 0$0i an4armf8alt:d eos2$r.ahr
Please enable JavaScript to view this content.
Novo Nordisk is now officially Lilly’s arch enemy! And lly, why decrease yearly guidance after just one quarter?! Stupid move. Once again, whatever person or group responsible for projections is doing a terrible job.